Science Advance: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors

By ACTSI investigator Stephen Traynelis, PhD (et al.)

Upcoming Events

    View All Events

    Latest News

    Training

    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

    Discovery

    Infographic: What are the Phases of Clinical Trials?